Interferon‐alpha modulates the chemosensitivity of CD133‐expressing pancreatic cancer cells to gemcitabine

Pancreatic cancer is a lethal disease as current chemotherapies with gemcitabine (GEM) are still insufficient. Accumulating evidence suggests that cancer stem cells (CSC) are responsible for chemoresistance and that CD133 is one of the CSC markers in pancreatic cancer. Interferon‐alpha (IFN‐α), a cy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Autores principales: Hayashi, Tomomi, Ding, Qiang, Kuwahata, Taisaku, Maeda, Koki, Miyazaki, Yumi, Matsubara, Shuichiro, Obara, Toru, Natsugoe, Shoji, Takao, Sonshin
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2012
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659312/
https://ncbi.nlm.nih.gov/pubmed/22320450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02235.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares